Henry Schein Stock (NASDAQ:HSIC)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$78.85

52W Range

$61.95 - $89.29

50D Avg

$75.15

200D Avg

$73.37

Market Cap

$9.14B

Avg Vol (3M)

$1.38M

Beta

0.82

Div Yield

-

HSIC Company Profile


Henry Schein, Inc. (HSIC) is a global leader in delivering a comprehensive suite of healthcare products and services. The company caters to a diverse clientele across the globe, including dental professionals and laboratories, physician practices, governmental entities, and various institutional and alternative healthcare facilities. Its operations are organized into two principal segments: Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution division supplies an extensive array of dental goods, encompassing consumables (such as infection control items, impression materials, composites, anesthetics, and artificial teeth), specialized tools and equipment (like handpieces, dental chairs, delivery units, X-ray machinery, and advanced digital restoration systems), and personal protective equipment. This segment also provides essential equipment repair services. Furthermore, it distributes a broad range of medical supplies, including pharmaceuticals (both branded and generic), vaccines, surgical instruments, diagnostic kits, infection prevention solutions, imaging products, equipment, and nutritional supplements. The Technology and Value-Added Services segment focuses on empowering practices with advanced software, technology, and supplementary solutions. This includes specialized practice management software systems tailored for both dental and medical professionals. Beyond software, it delivers crucial value-added practice support services, such as non-recourse financial assistance, electronic services, comprehensive technology and network infrastructure support, hardware services, ongoing professional development programs, and expert consulting. Established in 1932, Henry Schein, Inc. maintains its corporate headquarters in Melville, New York.

Show More

Industry

Medical - Distribution

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

25,000

IPO Date

Nov 03, 1995

Website

HSIC Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 18
Technology$509.25M
Healthcare Distribution$12.69B

Fiscal year ends in Dec 25 | Currency in USD

HSIC Financial Summary


Dec 25Dec 24Dec 23
Revenue$13.18B$12.67B$12.34B
Operating Income$758.00M$729.00M$714.00M
Net Income$398.00M$390.00M$416.00M
EBITDA$1.01B$941.00M$877.00M
Basic EPS$3.29$3.07$3.18
Diluted EPS$3.27$3.05$3.16

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q1 26May 05, 26 | 12:00 AM
Q4 25Feb 24, 26 | 12:00 AM
Q3 25Nov 04, 25 | 8:00 AM

Peer Comparison


TickerCompany
ATRAptarGroup, Inc.
BIOBio-Rad Laboratories, Inc.
MOHMolina Healthcare, Inc.
DVADaVita Inc.
GRFSGrifols, S.A.
AVTRAvantor, Inc.
GMEDGlobus Medical, Inc.
MASIMasimo Corporation
HALOHalozyme Therapeutics, Inc.